Abstract
A retrospective genotype and phenotype analysis of X-linked congenital nephrogenic diabetes insipidus (NDI) was conducted on a nationwide cohort of 25 (24 male, 1 female) Korean children with AVPR2 gene mutations, comparing non-truncating and truncating mutations. In an analysis of male patients, the median age at diagnosis was 0.9 years old. At a median follow-up of 5.4 years, urinary tract dilatations were evident in 62% of patients and their median glomerular filtration rate was 72 mL/min/1.73 m2. Weights and heights were under the 3rd percentile in 22% and 33% of patients, respectively. One patient had low intelligence quotient and another developed end-stage renal disease. No statistically significant genotype-phenotype correlation was found between non-truncating and truncating mutations. One patient was female; she was analyzed separately because inactivation and mosaicism of the X chromosome may influence clinical manifestations in female patients. Current unsatisfactory long-term outcome of congenital NDI necessitates a novel therapeutic strategy.
This study was supported by a grant (A120017) from the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea.
References
1. Cheong HI, Park HW, Ha IS, Moon HN, Choi Y, et al. Six novel mutations in the vasopressin V2 receptor gene causing nephrogenic diabetes insipidus. Nephron 1997;75:431–7.10.1159/000189581Search in Google Scholar
2. Bichet DG. V2R mutations and nephrogenic diabetes insipidus. Prog Mol Biol Transl Sci 2009;89:15–29.10.1016/S1877-1173(09)89002-9Search in Google Scholar
3. Knoers NV, Deen PM. Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol 2001;16: 1146–52.10.1007/s004670100051Search in Google Scholar
4. Cheong HI, Cho SJ, Zheng SH, Cho HY, Ha IS, et al. Two novel mutations in the aquaporin 2 gene in a girl with congenital nephrogenic diabetes insipidus. J Korean Med Sci 2005;20:1076–8.10.3346/jkms.2005.20.6.1076Search in Google Scholar
5. van Lieburg AF, Knoers NV, Monnens LA. Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 1999;10:1958–64.10.1681/ASN.V1091958Search in Google Scholar
6. Lejarraga H, Caletti MG, Caino S, Jimenez A. Long-term growth of children with nephrogenic diabetes insipidus. Pediatr Nephrol 2008;23:2007–12.10.1007/s00467-008-0844-8Search in Google Scholar
7. Hoekstra JA, van Lieburg AF, Monnens LA, Hulstijn-Dirkmaat GM, Knoers VV. Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet 1996;61:81–8.10.1002/(SICI)1096-8628(19960102)61:1<81::AID-AJMG17>3.0.CO;2-SSearch in Google Scholar
8. Yoo TH, Ryu DR, Song YS, Lee SC, Kim HJ, et al. Congenital nephrogenic diabetes insipidus presented with bilateral hydronephrosis: genetic analysis of V2R gene mutations. Yonsei Med J 2006;47:126–30.10.3349/ymj.2006.47.1.126Search in Google Scholar
9. Migeon BR. X inactivation, female mosaicism, and sex differences in renal diseases. J Am Soc Nephrol 2008;19: 2052–9.10.1681/ASN.2008020198Search in Google Scholar
10. Faerch M, Corydon TJ, Rittig S, Christensen JH, Hertz JM, et al. Skewed X-chromosome inactivation causing diagnostic misinterpretation in congenital nephrogenic diabetes insipidus. Scand J Urol Nephrol 2010;44:324–30.10.3109/00365599.2010.482946Search in Google Scholar
11. Uribarri J, Kaskas M. Hereditary nephrogenic diabetes insipidus and bilateral nonobstructive hydronephrosis. Nephron 1993;65:346–9.10.1159/000187510Search in Google Scholar
12. Hora M, Reischig T, Hes O, Ferda J, Klecka J. Urological complications of congenital nephrogenic diabetes insipidus – long-term follow-up of one patient. Int Urol Nephrol 2006;38:531–2.10.1007/s11255-006-0093-3Search in Google Scholar
13. Mizuno H, Sugiyama Y, Ohro Y, Imamine H, Kobayashi M, et al. Clinical characteristics of eight patients with congenital nephrogenic diabetes insipidus. Endocrine 2004;24:55–9.10.1385/ENDO:24:1:055Search in Google Scholar
14. Higuchi A, Kawamura T, Nakai H, Hasegawa Y. Infrequent voiding in nephrogenic diabetes insipidus as a cause of renal failure. Pediatr Int 2002;44:540–2.10.1046/j.1442-200X.2002.01599.xSearch in Google Scholar
15. Wesche D, Deen PM, Knoers NV. Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol 2012;27:2183–204.10.1007/s00467-012-2118-8Search in Google Scholar PubMed
16. Verpoorten C, Buyse GM. The neurogenic bladder: medical treatment. Pediatr Nephrol 2008;23:717–25.10.1007/s00467-007-0691-zSearch in Google Scholar PubMed PubMed Central
17. Kurzrock EA, Polse S. Renal deterioration in myelodysplastic children: urodynamic evaluation and clinical correlates. J Urol 1998;159:1657–61.10.1097/00005392-199805000-00084Search in Google Scholar PubMed
18. Arthus MF, Lonergan M, Crumley MJ, Naumova AK, Morin D, et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 2000;11:1044–54.10.1681/ASN.V1161044Search in Google Scholar PubMed
©2014 by Walter de Gruyter Berlin Boston
